PASTORE, GABIRIA
 Distribuzione geografica
Continente #
EU - Europa 2.199
NA - Nord America 1.799
AS - Asia 957
SA - Sud America 155
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 50
OC - Oceania 3
Totale 5.258
Nazione #
US - Stati Uniti d'America 1.734
IT - Italia 669
RU - Federazione Russa 541
SG - Singapore 294
CN - Cina 228
IE - Irlanda 225
DE - Germania 179
GB - Regno Unito 164
BR - Brasile 118
VN - Vietnam 118
FI - Finlandia 117
HK - Hong Kong 103
FR - Francia 79
SE - Svezia 68
KR - Corea 52
IN - India 44
CA - Canada 34
ZA - Sudafrica 31
NL - Olanda 30
BD - Bangladesh 25
ES - Italia 25
PL - Polonia 19
UA - Ucraina 14
CZ - Repubblica Ceca 12
IL - Israele 12
CH - Svizzera 9
IQ - Iraq 9
MX - Messico 9
UZ - Uzbekistan 9
AR - Argentina 8
AT - Austria 8
CI - Costa d'Avorio 7
JP - Giappone 7
BE - Belgio 6
SA - Arabia Saudita 6
TR - Turchia 6
VE - Venezuela 6
CR - Costa Rica 5
IR - Iran 5
LT - Lituania 5
PY - Paraguay 5
GP - Guadalupe 4
GR - Grecia 4
ID - Indonesia 4
NP - Nepal 4
PT - Portogallo 4
TH - Thailandia 4
AL - Albania 3
CL - Cile 3
CO - Colombia 3
EC - Ecuador 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
PE - Perù 3
RO - Romania 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
MD - Moldavia 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
PR - Porto Rico 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MT - Malta 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SR - Suriname 1
Totale 5.166
Città #
Dallas 294
Dublin 224
Singapore 179
San Jose 170
Moscow 148
Ashburn 143
Milan 127
Munich 112
Southend 105
Santa Clara 99
Siena 99
Hong Kong 96
Helsinki 85
Chandler 73
Rome 63
Beijing 59
Florence 57
Hefei 55
Los Angeles 55
Fairfield 54
New York 51
Seoul 48
Ho Chi Minh City 42
Council Bluffs 38
Woodbridge 31
Hanoi 28
Johannesburg 28
The Dalles 28
Houston 26
Princeton 21
Seattle 21
Lappeenranta 20
Cambridge 19
Frankfurt am Main 19
Lauterbourg 19
Shanghai 18
Wilmington 18
Dong Ket 17
Ann Arbor 16
Montreal 15
Orem 15
São Paulo 15
Chicago 14
London 13
Boardman 12
Düsseldorf 12
Buffalo 11
Columbus 11
Fremont 11
Jacksonville 11
Málaga 10
Turku 10
Bengaluru 9
Denver 9
Mumbai 9
Nuremberg 9
Tashkent 9
Warsaw 9
Amsterdam 8
Atlanta 8
Figino 8
Messina 8
Phoenix 8
Poggibonsi 8
Portsmouth 8
Abidjan 7
Bologna 7
Brno 7
Chennai 7
Madrid 7
Menlo Park 7
Salt Lake City 7
Toronto 7
Washington 7
Bacoli 6
Brescia 6
Brooklyn 6
Brussels 6
Charlotte 6
Guangzhou 6
Naples 6
North Bergen 6
Redondo Beach 6
Salerno 6
Baronissi 5
Dearborn 5
Gurugram 5
Palermo 5
San Diego 5
Tokyo 5
Agliana 4
Barolo 4
Figline Valdarno 4
Goyang-si 4
Lanciano 4
Newark 4
Olomouc 4
Paris 4
Rio de Janeiro 4
Roccagorga 4
Totale 3.268
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 378
Type M Resistance to Macrolides Is Due to a Two-Gene Efflux Transport System of the ATP-Binding Cassette (ABC) Superfamily 337
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 315
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 303
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 297
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 255
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 253
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 234
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 233
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 215
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 213
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 207
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 204
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 203
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 199
Streptococcus pyogenes Φ1207.3 Is a Temperate Bacteriophage Carrying the Macrolide Resistance Gene Pair mef(A)-msr(D) and Capable of Lysogenizing Different Streptococci 196
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 195
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 174
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 171
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 169
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 137
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 123
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 109
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome 51
Machine learning approaches to dissect hybrid and vaccine-induced immunity 47
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV 40
Totale 5.258
Categoria #
all - tutte 17.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022150 0 0 0 0 11 4 14 7 20 12 37 45
2022/2023370 22 46 58 29 25 39 19 26 16 18 52 20
2023/2024520 8 8 45 53 27 128 147 10 16 32 9 37
2024/2025995 48 31 124 55 91 59 78 82 116 43 85 183
2025/20262.307 157 267 281 315 469 64 239 54 93 131 89 148
2026/2027443 75 77 127 108 56 0 0 0 0 0 0 0
Totale 5.258